Keskenmeno, näytönastekatsausten kirjallisuusviitteet

Kirjallisuutta

1. Subtil D, Brabant G, Tilloy E, ym. Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial. Lancet 2018;392(10160):2171-2179 «PMID: 30322724»PubMed
2. Wu J, Zhu X, Tang B, ym. Effects of bacterial vaginosis treatment during pregnancy on maternal-fetal outcome: A systematic review and network meta-analysis. Eur J Obstet Gynecol Reprod Biol 2025;307():175-183 «PMID: 39946993»PubMed
3. Balogun OO, da Silva Lopes K, Ota E, ym. Vitamin supplementation for preventing miscarriage. Cochrane Database Syst Rev 2016;2016(5):CD004073 «PMID: 27150280»PubMed
4. Zhang H, Huang Z, Xiao L, ym. Meta-analysis of the effect of the maternal vitamin D level on the risk of spontaneous pregnancy loss. Int J Gynaecol Obstet 2017;138(3):242-249 «PMID: 28500757»PubMed
5. Fernlund A, Jokubkiene L, Sladkevicius P, ym. Misoprostol treatment vs expectant management in women with early non-viable pregnancy and vaginal bleeding: a pragmatic randomized controlled trial. Ultrasound Obstet Gynecol 2018;51(1):24-32 «PMID: 29072372»PubMed
6. Okeke Ogwulu CB, Williams EV, Chu JJ, ym. Cost-effectiveness of mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage: an economic evaluation based on the MifeMiso trial. BJOG 2021;128(9):1534-1545 «PMID: 33969614»PubMed
7. Hamel C, Coppus S, van den Berg J, ym. Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind placebo-controlled randomised trial. EClinicalMedicine 2021;32():100716 «PMID: 33681738»PubMed
8. Islam N, Furuya-Kanamori L, Mahmood S, ym. Prophylactic antibiotics for preventing genital tract infection in women undergoing surgical procedures for incomplete abortion: a systematic review and meta-analysis of randomised controlled trials. BJOG 2021;128(8):1273-1281 «PMID: 33346920»PubMed
9. Ahmed SI, Ammerdorffer A, Moakes CA, ym. Prophylactic antibiotics for uterine evacuation procedures to manage miscarriage. Cochrane Database Syst Rev 2025;4(4):CD014844 «PMID: 40231786»PubMed
10. Horvath S, Tsao P, Huang ZY, ym. The concentration of fetal red blood cells in first-trimester pregnant women undergoing uterine aspiration is below the calculated threshold for Rh sensitization. Contraception 2020;102(1):1-6 «PMID: 32135125»PubMed
11. Horvath S, Huang ZY, Koelper NC, ym. Induced Abortion and the Risk of Rh Sensitization. JAMA 2023;330(12):1167-1174 «PMID: 37750879»PubMed
12. Wiebe ER, Campbell M, Aiken ARA ym. Can we safely stop testing for Rh status and immunizing Rh-negative women having early abortions? A comparison of Rh alloimmunization in Canada and the Netrherlands. Contraception: X 2019;1:100001
13. Quenby S, Booth K, Hiller L, ym. Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial. Lancet 2023;402(10395):54-61 «PMID: 37271152»PubMed
14. Skeith L, Carrier M, Kaaja R, ym. A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia. Blood 2016;127(13):1650-5 «PMID: 26837697»PubMed
15. Kangatharan C, Labram S, Bhattacharya S. Interpregnancy interval following miscarriage and adverse pregnancy outcomes: systematic review and meta-analysis. Hum Reprod Update 2017;23(2):221-231 «PMID: 27864302»PubMed
16. Report of a WHO Technical Consultation on Birth Spacing. WHO 2005 https://www.who.int/publications/i/item/WHO-RHR-07.1
17. Conde-Agudelo A, Belizán JM, Breman R, ym. Effect of the interpregnancy interval after an abortion on maternal and perinatal health in Latin America. Int J Gynaecol Obstet 2005;89 Suppl 1():S34-40 «PMID: 15820366»PubMed
18. Pasquier E, de Saint Martin L, Bohec C, ym. Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial. Blood 2015;125(14):2200-5 «PMID: 25636341»PubMed
19. Schleussner E, Kamin G, Seliger G, ym. Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme. Ann Intern Med 2015;162(9):601-9 «PMID: 25938990»PubMed
20. de Jong PG, Kaandorp S, Di Nisio M, ym. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. Cochrane Database Syst Rev 2014;2014(7):CD004734 «PMID: 24995856»PubMed
21. Blomqvist L, Hellgren M, Strandell A. Acetylsalicylic acid does not prevent first-trimester unexplained recurrent pregnancy loss: A randomized controlled trial. Acta Obstet Gynecol Scand 2018;97(11):1365-1372 «PMID: 29972884»PubMed
22. Schisterman EF, Silver RM, Lesher LL, ym. Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial. Lancet 2014;384(9937):29-36 «PMID: 24702835»PubMed
23. Coomarasamy A, Williams H, Truchanowicz E, ym. PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation. Health Technol Assess 2016;20(41):1-92 «PMID: 27225013»PubMed